穿戴式裝置在氣喘管理的應用－2026-2031年預測

預計氣喘管理穿戴裝置市場將維持 8.16% 的複合年成長率，從 2025 年的 991,559,000 美元成長到 2031 年的 1,587,315,000 美元。

專用於氣喘管理的穿戴式裝置市場正在迅速擴張，標誌著慢性呼吸系統疾病治療模式的重大轉變。這些技術超越了傳統的被動監測，提供數據驅動的主動管理工具，從而增強患者的自主性並革新臨床決策。

核心價值提案與臨床需求

氣喘穿戴裝置的根本價值在於其能夠持續、即時地提供患者呼吸狀況和環境資訊。透過監測呼吸模式、肺功能和吸氣動態等關鍵生理參數，這些設備可以建構疾病的全面縱向圖譜。這種持續的數據流使得早期發現氣喘急性發作的預警訊號成為可能，遠比常規症狀報告或診室肺功能檢查所能達到的更早。

這項功能滿足了一項重要的臨床需求：預防嚴重氣喘發作並減少相關的急性醫療事件。顯著減少氣喘相關住院和急診就診的潛力，對醫療保健系統而言意義重大。透過促進及時干預，例如藥物調配、避免誘發因素和諮詢醫生，穿戴式裝置有助於控制症狀、提高生活品質，並減輕急診和住院服務的整體負擔。

主要市場促進因素

市場擴張是由多種協同因素所驅動的。氣喘在全球持續高發生率，導致龐大且穩定的患者族群亟需有效的管理方案。穿戴式感測器技術的同步發展正滿足這項臨床需求，使得更小巧、更精準、更易用的設備得以開發，能夠可靠地追蹤複雜的呼吸指標。

病人賦能和積極自我管理的文化轉變是推動穿戴式裝置普及的關鍵因素。患者越來越希望在自身健康管理中扮演積極的角色，而穿戴式裝置恰好為他們提供了所需的工具。這些設備能夠直接向使用者提供關於症狀、誘發因素和用藥依從性的個人化訊息，從而將氣喘管理從被動應對轉變為主動預防。這種日益增強的自我管理意識和需求與穿戴式科技的功能完美契合。

此外，遠端患者監護和遠端醫療與標準護理模式的廣泛融合正在加速市場接受度。穿戴式裝置作為這些虛擬照護路徑中的數據生成前端，為臨床醫生提供客觀的真實世界數據，以指導遠距照護協調，從而與改善傳統臨床環境之外的慢性病管理這一系統性目標相契合。

市場區隔與技術整合

該市場圍繞著核心功能構建，由既獨立又相互重疊的細分市場組成。其中一個主要細分市場專注於生理監測，利用穿戴式感測器追蹤肺功能、呼吸頻率和其他生命徵象。另一個重要細分市場圍繞著藥物依從性和管理展開，利用連網智慧吸入器和感測器記錄使用數據，包括每次用藥的時間、方法和環境背景。

這些資料流的融合才能真正發揮最大價值。前沿解決方案將生理監測數據與用藥數據和環境數據（例如花粉計數、空氣品質）相結合，從而全面了解個體的氣喘狀況。這種整合方法能夠提供真正個人化的洞察，識別特定的誘發因素，並評估處方療法在實際應用中的有效性。

區域創新中心

北美憑藉先進的醫療基礎設施、高氣喘盛行率以及強大的數位醫療創新生態系統，在該市場保持主導地位。該地區專注於以價值為導向的醫療保健和慢性病管理，為那些能夠改善療效並降低成本的技術創造了有利環境。北美醫療技術公司、製藥公司、醫療服務提供者和學術機構之間的積極合作，促進了產品的持續研發和臨床檢驗。

競爭格局與解決方案原型

競爭格局多元化，既有專注於數位醫療領域的公司，也有醫療設備與製藥公司之間的合作專案。主要競爭對手的差異體現在各自的技術重點、數據分析能力以及與更廣泛醫療平台的整合。

關鍵解決方案原型包括用於監測肺功能和呼吸模式的專用穿戴式監測器，以及可連接到現有吸入器以追蹤使用情況的智慧吸入器感測器，通常與複雜的行動應用程式配合使用，以整合數據、向患者提供反饋和教育，並促進與醫療保健提供者以及在某些情況下與看護者的數據共用。

未來發展及策略意義

該市場的未來發展將側重於更深入的臨床整合和更先進的預測能力。未來的發展將著重於增強這些平台內建的預測分析能力，從說明數據報告轉向指導性警報和個人化建議。利用人工智慧辨識個別病情加重的徵兆將是一項關鍵的尖端技術。

另一個重要發展是向多疾病平台轉型，氣喘管理將成為更廣泛的呼吸系統和慢性病管理生態系統中的一個模組。與電子健康記錄和遠端醫療平台的互通性對於在醫療保健系統中廣泛應用也至關重要。

對相關人員而言，成功與否取決於能否透過改善健康結果和降低急診護理成本來證明其具有明顯的臨床效用和投資回報。透過臨床研究累積可靠的證據、建立將軟體作為醫療設備的監管途徑，以及確保流暢的使用者體驗以維持病人參與，這些都是關鍵的策略重點。用於氣喘管理的穿戴式設備將成為以患者為中心的現代化預防性呼吸系統健康方法的重要組成部分。

本報告的主要優勢：

• 深入分析：獲得主要和新興地區的深入市場洞察，重點關注客戶群、政府政策和社會經濟因素、消費者偏好、行業垂直領域和其他細分市場。
• 競爭格局：了解全球主要參與者的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
• 市場促進因素與未來趨勢：探索市場促進因素和關鍵趨勢，以及它們將如何塑造未來的市場發展。
• 可操作的建議：利用這些見解，在動態環境中做出策略決策，並開拓新的商機和收入來源。
• 受眾廣泛：對Start-Ups、研究機構、顧問公司、中小企業和大型企業都很有用且經濟實惠。

它是用來做什麼的？

產業與市場分析、機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法規結構及影響、新產品開發、競爭情報

報告範圍：

• 2021年至2025年的歷史數據和2026年至2031年的預測數據
• 成長機會、挑戰、供應鏈前景、法規結構與趨勢分析
• 競爭定位、策略和市場佔有率分析
• 按業務板塊和地區（包括國家）分類的收入和預測評估
• 公司概況（策略、產品、財務資訊、關鍵發展等）

目錄

第1章執行摘要

第2章 市場概覽

• 市場概覽
• 市場定義
• 調查範圍
• 市場區隔

第3章 商業情境

• 市場促進因素
• 市場限制
• 市場機遇
• 波特五力分析
• 產業價值鏈分析
• 政策與法規
• 策略建議

第4章 技術展望

第5章氣喘管理穿戴裝置市場（按類型分類）

• 介紹
• 智慧吸入器
• 穿戴式肺功能監測器
• 具備氣喘監測功能的活動追蹤器

6. 按技術分類的氣喘管理穿戴裝置市場

• 介紹
• 藍牙連接
• 感測器技術
• 行動應用與平台

第7章 依應用分類的氣喘管理穿戴裝置市場

• 介紹
• 氣喘症狀監測
• 藥物依從性追蹤
• 峰值流速監測
• 識別觸發因素
• 個人化氣喘管理

第8章 按最終用戶分類的氣喘管理穿戴式裝置市場

• 介紹
• 氣喘患者
• 醫療保健提供者
• 醫院和診所
• 研究所

9. 各地區氣喘管理穿戴裝置市場

• 介紹
• 北美洲
  • 美國
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他
• 歐洲
  • 德國
  • 法國
  • 英國
  • 西班牙
  • 其他
• 中東和非洲
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 印尼
  • 泰國
  • 其他

第10章 競爭格局與分析

• 主要企業和策略分析
• 市佔率分析
• 合併、收購、協議和合作
• 競爭對手儀錶板

第11章：公司簡介

• Propeller Health（Now Part Of Resmed）
• Adherium Limited
• Teva Pharmaceuticals
• Cohero Health
• Nuvoair
• Astrazeneca Plc
• Health Care Originals
• Inspirx, Inc.
• Amiko Digital Health Limited
• Healthimation, Llc

第12章附錄

• 貨幣
• 先決條件
• 基準年和預測年時間表
• 相關人員的主要收益
• 調查方法
• 簡稱

Wearables For Asthma Management Market, sustaining a 8.16% CAGR, is forecasted to rise from USD 991.559 million in 2025 to USD 1587.315 million in 2031.

The market for wearable devices dedicated to asthma management is expanding rapidly, representing a significant shift in the paradigm of chronic respiratory care. These technologies are moving beyond traditional passive monitoring to offer proactive, data-driven management tools that empower patients and transform clinical decision-making.

Core Value Proposition and Clinical Imperative

The fundamental value of asthma wearables lies in their ability to provide continuous, real-time insights into a patient's respiratory status and environmental context. By monitoring key physiological parameters such as breathing patterns, lung function, and inhalation mechanics, these devices create a comprehensive, longitudinal profile of the disease. This continuous data stream enables the detection of early warning signs of exacerbation, far earlier than periodic symptom reporting or spirometry in a clinic can achieve.

This capability addresses a critical clinical need: the prevention of severe asthma attacks and the reduction of associated acute care events. The potential to significantly decrease asthma-related hospitalizations and emergency room visits represents a primary value driver for healthcare systems. By facilitating timely interventions-such as adjusting medication, avoiding triggers, or consulting a provider-wearables can help maintain control, improve quality of life, and reduce the overall burden on emergency and inpatient services.

Key Market Growth Drivers

Market expansion is fueled by several synergistic factors. The persistent and high global prevalence of asthma establishes a substantial and sustained patient population in need of effective management solutions. This clinical demand is met by parallel advancements in wearable sensor technology, which have enabled the development of smaller, more accurate, and more user-friendly devices capable of reliably tracking complex respiratory metrics.

A powerful cultural shift toward patient empowerment and proactive self-management is a critical adoption driver. Patients are increasingly seeking active roles in their healthcare, and wearables provide the necessary tools. By delivering personalized insights on symptoms, triggers, and medication adherence directly to the user, these devices transform asthma management from a reactive to a proactive endeavor. This growing awareness and desire for self-care aligns perfectly with the functionality of wearable technologies.

Furthermore, the broader integration of remote patient monitoring and telehealth into standard care models accelerates market acceptance. Wearables serve as the data-generating front end for these virtual care pathways, providing clinicians with objective, real-world evidence to guide treatment adjustments remotely. This aligns with systemic goals to improve chronic disease management outside traditional clinical settings.

Market Segmentation and Technological Integration

The market comprises distinct but overlapping segments centered on core functionalities. A primary segment is focused on physiological monitoring, utilizing wearable sensors to track lung function, respiratory rate, and other biometrics. A second, crucial segment revolves around medication adherence and management, featuring connected smart inhalers and sensors that record usage data, including timing, technique, and environmental context of each dose.

The convergence of these data streams is where maximal value is created. The most advanced solutions integrate physiological monitoring with medication use and environmental data (e.g., pollen count, air quality) to build a holistic understanding of an individual's asthma. This integrated approach enables truly personalized insights, identifying specific triggers and evaluating the real-world effectiveness of prescribed therapies.

Geographic Landscape and Innovation Hubs

North America maintains a leadership position in this market, driven by a confluence of advanced healthcare infrastructure, a high prevalence of asthma, and a robust ecosystem for digital health innovation. The region's focus on value-based care and chronic disease management creates a receptive environment for technologies that demonstrate improved outcomes and cost savings. Active collaboration between medical technology companies, pharmaceutical firms, healthcare providers, and academic institutions in North America fosters continuous product development and clinical validation.

Competitive Landscape and Solution Archetypes

The competitive landscape features a diverse array of players, including specialized digital health companies and partnerships between device manufacturers and pharmaceutical entities. Key competitors are differentiated by their specific technological focus, data analytics capabilities, and integration into broader care platforms.

Primary solution archetypes include dedicated wearable monitors for lung function and breathing patterns, and smart inhaler sensors that attach to existing inhalers to track usage. These are typically paired with sophisticated mobile applications that aggregate data, provide patient feedback and education, and facilitate data sharing with healthcare providers and, in some cases, caregivers.

Future Trajectory and Strategic Implications

The forward trajectory for this market points toward deeper clinical integration and more intelligent predictive capabilities. Future development will focus on enhancing the predictive analytics embedded within these platforms, moving from descriptive data reporting to prescriptive alerts and personalized recommendations. The integration of artificial intelligence to identify individual exacerbation precursors represents a significant frontier.

Another key evolution will be the move toward multi-condition platforms, where asthma management is one module within a broader respiratory or chronic disease management ecosystem. Interoperability with electronic health records and telehealth platforms will also be critical for scaling adoption within health systems.

For industry stakeholders, success will depend on demonstrating clear clinical utility and a return on investment through improved health outcomes and reduced acute care costs. Building robust evidence through clinical studies, navigating regulatory pathways for software as a medical device, and ensuring seamless user experiences to maintain patient engagement are all critical strategic priorities. Wearables for asthma management are poised to become an indispensable component of a modern, preventative, and patient-centered approach to respiratory health.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.)

Wearables for Asthma Management Market Segmentation

• By Type
• Smart Inhalers
• Wearable Spirometers
• Activity Trackers With Asthma Monitoring
• By Technology
• Bluetooth Connectivity
• Sensor Technology
• Mobile Apps And Platforms
• By Application
• Asthma Symptom Monitoring
• Medication Adherence Tracking
• Peak Flow Rate Monitoring
• Trigger Identification
• Personalized Asthma Management
• By End-User
• Patients With Asthma
• Healthcare Providers
• Hospitals And Clinics
• Research Institutions
• By Geography
• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TYPE

• 5.1. Introduction
• 5.2. Smart Inhalers
• 5.3. Wearable Spirometers
• 5.4. Activity Trackers With Asthma Monitoring

6. WEARABLES FOR ASTHMA MANAGEMENT MARKET BY TECHNOLOGY

• 6.1. Introduction
• 6.2. Bluetooth Connectivity
• 6.3. Sensor Technology
• 6.4. Mobile Apps And Platforms

7. WEARABLE FOR ASTHMA MANAGEMENT MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Asthma Symptom Monitoring
• 7.3. Medication Adherence Tracking
• 7.4. Peak Flow Rate Monitoring
• 7.5. Trigger Identification
• 7.6. Personalized Asthma Management

8. WEARABLE FOR ASTHMA MANAGEMENT MARKET BY END-USER

• 8.1. Introduction
• 8.2. Patients With Asthma
• 8.3. Healthcare Providers
• 8.4. Hospitals And Clinics
• 8.5. Research Institutions

9. WEARABLE FOR ASTHMA MANAGEMENT MARKET BY GEOGRAPHY

• 9.1. Introduction
• 9.2. North America
  • 9.2.1. USA
  • 9.2.2. Canada
  • 9.2.3. Mexico
• 9.3. South America
  • 9.3.1. Brazil
  • 9.3.2. Argentina
  • 9.3.3. Others
• 9.4. Europe
  • 9.4.1. Germany
  • 9.4.2. France
  • 9.4.3. United Kingdom
  • 9.4.4. Spain
  • 9.4.5. Others
• 9.5. Middle East and Africa
  • 9.5.1. Saudi Arabia
  • 9.5.2. UAE
  • 9.5.3. Others
• 9.6. Asia Pacific
  • 9.6.1. China
  • 9.6.2. India
  • 9.6.3. Japan
  • 9.6.4. South Korea
  • 9.6.5. Indonesia
  • 9.6.6. Thailand
  • 9.6.7. Others

10. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 10.1. Major Players and Strategy Analysis
• 10.2. Market Share Analysis
• 10.3. Mergers, Acquisitions, Agreements, and Collaborations
• 10.4. Competitive Dashboard

11. COMPANY PROFILES

• 11.1. Propeller Health (Now Part Of Resmed)
• 11.2. Adherium Limited
• 11.3. Teva Pharmaceuticals
• 11.4. Cohero Health
• 11.5. Nuvoair
• 11.6. Astrazeneca Plc
• 11.7. Health Care Originals
• 11.8. Inspirx, Inc.
• 11.9. Amiko Digital Health Limited
• 11.10. Healthimation, Llc

12. APPENDIX

• 12.1. Currency
• 12.2. Assumptions
• 12.3. Base and Forecast Years Timeline
• 12.4. Key Benefits for the Stakeholders
• 12.5. Research Methodology
• 12.6. Abbreviations